Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/4/26 19:25 | 5/4/26 | TRDA | Health | Drug | Pharmaceutical Preparations | Sethuraman Natarajan | MA | O | P,Resear | 1 | S | -399 | 15.39 | 0 | -26 | 216 | D | |||||||||||||||
5/4/26 19:24 | 5/4/26 | TRDA | Health | Drug | Pharmaceutical Preparations | Dowden Nathan J | MA | O | P,COO | 2 | S.dm | -426 | 14.19 | 0 | -30 | 199 | D | |||||||||||||||
4/2/26 16:39 | 4/1/26 | TRDA | Health | Drug | Pharmaceutical Preparations | Wentworth Kory James | MA | O | CFO | 5 | S.m | -453 | 12.02 | 0 | -38 | 138 | D | |||||||||||||||
11/18/25 16:36 | 11/14/25 | TRDA | Health | Drug | Pharmaceutical Preparations | Parmar Kush | CA | DT | 3 | S.m | -2,829 | 8.04 | 0 | -352 | 4,283 | I | ||||||||||||||||
11/18/25 16:34 | 7/9/25 | TRDA | Health | Drug | Pharmaceutical Preparations | 5Am Ventures V, L.P. | CA | T | 3 | S.m | -2,829 | 8.04 | 0 | -352 | 4,283 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |